AtCor wins two more supply contracts for SphygmoCor, worth $1.66M [ + ]

Genetic Technologies responds to criticism over patent enforcement decision [ + ]

Genetic Technologies acquires Frozen Puppies Dot Com [ + ]

Israeli trial due for completion in 2009, commercialisation as nutritional to follow [ + ]

Massive share price plunge as Progen abandons lead compound trial [ + ]

Applications for the Pfizer Australia Research Fellowships close on Monday [ + ]

The annual Australian Biotechnology Summit begins next week [ + ]

Phase I trial of neuropathic pain candidate successful [ + ]

Roche offers to buy out remaining Genentech shares for A$45 billion [ + ]

A new $30 million federal government-funded Cooperative Research Centre for Biomarker Translation (CRC-BT) has been launched at La Trobe University Research and Development Park. Core partners in the new CRC are La Trobe University and the Macfarlane Burnett Institute for Medical Research and Public Health in Melbourne; the Mater Medical Research Institute and Mater Health Services in Brisbane; and the Women & Children’s Health Research Institute and Institute of Medical and Veterinary Science in Adelaide. US-based biotechnology corporations Amgen and Becton Dickinson Biosciences are the commercial CRC-BT partners.

Swedish researchers track down the mutation that causes horses to go grey [ + ]

Researchers discover Lrh1 gene regulates and blocks ovulation [ + ]

Mediation and $20 million allows Biota and GSK to conclude litigation over Relenza [ + ]

Deloitte completes acquisition of Recombinant Capital [ + ]

Norwood Abbey subsidiary's technology to be evaluated by MedImmune [ + ]